Filing Details
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) filed a Form 8-K with the Securities and Exchange Commission on October 13, 2026, disclosing a material event.
8k filedNASDAQ:MIRM
Mirum Pharmaceuticals, Inc. (MIRM) Reports Material Event to SEC
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) filed a Form 8-K with the Securities and Exchange Commission on October 13, 2026, disclosing a material event.
At publication ·
What changed
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Mirum Pharmaceuticals filed a Form 8-K with the SEC on October 13, 2026, disclosing a material event that shareholders should monitor.
- The company's stock trades at $79.62 with a market capitalization of $3.2 billion.
- 8-K filings typically report significant events such as leadership changes, material agreements, acquisitions, or asset sales between regular reports.
Market Context
Mirum Pharmaceuticals, Inc.'s stock currently trades at $79.62 with a market capitalization of $3.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Mirum Pharmaceuticals, Inc.'s stock.
All SEC filings for Mirum Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MIRM Stock Page
Frequently Asked Questions
Where can I read MIRM's SEC filings?
Browse all filings on our MIRM SEC filings page.
What types of SEC filings does Mirum Pharmaceuticals, Inc. file?
Public companies like Mirum Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.